EQS-Adhoc: LifeWatch AG: Whistleblower case settled

   Dow Jones received a payment from EQS/DGAP to publish this press release.

EQS Group-Ad-hoc: LifeWatch AG / Key word(s): Legal Matter LifeWatch AG: Whistleblower case settled

08-March-2017 / 06:55 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 KR

Whistleblower case settled

Zug/Switzerland - LifeWatch AG (SIX Swiss Exchange: LIFE), a leading developer and provider of medical solutions and remote diagnostic monitoring services in the digital health market, is pleased to announce that the federal claims in the _qui tam_ ("whistleblower"), case brought, in part, on behalf of the federal government payors, Medicare, TriCare and Veterans Administration have been dismissed with prejudice.

LifeWatch Services, Inc., the U.S. subsidiary of LifeWatch AG, was sued in a _qui tam_, action in May of 2013. As previously communicated last June, the Relator and LifeWatch settled the case for USD $12.75 million pending final approval by the Unites States Federal Government. All federal government approvals have been received and payments all have now been made. Consequently, on March 6, 2017, the federal court entered an order dismissing, with prejudice, all claims for these federal healthcare programs.

Additionally, settlement of the dispute regarding the Medicaid programs for four remaining states has been agreed to, in principle, totaling approximately USD $50,000 to be paid out of the same agreed settlement amount. The settlements with these states should be completed in approximately six weeks.

LifeWatch is pleased to place this matter behind it and focus on a strong 2017.

About LifeWatch AG

LifeWatch AG, headquartered in Zug and listed on SIX Swiss Exchange (LIFE), Switzerland, is a leading healthcare technology and solution company, specializing in advanced digital health systems and wireless remote diagnostic patient monitoring services. LifeWatch's services provide physicians with critical information to determine appropriate treatment and thereby improve patient outcomes. LifeWatch AG has operative subsidiaries in the United States, in Switzerland and in Israel, and is the parent company of LifeWatch Services Inc., and LifeWatch Technologies, Ltd. LifeWatch Services, Inc. is a leading U.S.-based provider of cardiac monitoring services. LifeWatch Technologies Ltd., based in Israel, is a leading developer and manufacturer of telemedicine products. For additional information, please visit www.lifewatch.com [1].

Sign up for customized e-mail alerts and documentation requests at https://www.lifewatch.com/Investor-Relations/Alert-Service.html [2]

This press release includes forward-looking statements. All statements other than statements of historical facts contained in this press release, including statements regarding future results of operations and financial position, the business strategy, and plans and objectives for future operations, are forward-looking statements. The words "believe," "may," "will," "estimate," "continue," "anticipate," "intend," "expect" and similar expressions are intended to identify forward-looking statements. LifeWatch AG has based these forward-looking statements largely on current expectations and projections about future events and financial trends that it believes may affect the financial condition, results of operations, business strategy, short-term and long-term business operations and objectives, and financial needs. These forward-looking statements are subject to a number of risks, uncertainties and assumptions. In light of these risks, uncertainties and assumptions, the forward-looking events and circumstances described may not occur and actual results could differ materially and adversely from those anticipated or implied in the forward-looking statements. All forward-looking statements are based only on data available to LifeWatch AG at the time of the issue of this press release. LifeWatch AG does not undertake any obligation to update any forward-looking statements contained in this press release as a result of new information, future events or otherwise.

THIS PRESS RELEASE IS NOT BEING ISSUED IN THE UNITED STATES OF AMERICA AND MUST NOT BE DISTRIBUTED TO UNITED STATES PERSONS OR PUBLICATIONS WITH A GENERAL CIRCULATION IN THE UNITED STATES. THIS PRESS RELEASE DOES NOT CONSTITUTE AN OFFER OF SECURITIES OF LIFEWATCH AG OR ANY OF ITS SUBSIDIARIES FOR SALE IN THE UNITED STATES, OR AN INVITATION TO SUBSCRIBE FOR OR PURCHASE ANY SECURITIES OF LIFEWATCH AG OR ITS SUBSIDIARIES IN THE UNITED STATES. IN ADDITION, THE SECURITIES OF LIFEWATCH AG AND ITS SUBSIDIARIES HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES LAWS AND MAY NOT BE OFFERED, SOLD OR DELIVERED WITHIN THE UNITED STATES OR TO U.S. PERSONS ABSENT FROM REGISTRATION UNDER OR AN APPLICABLE EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE UNITED STATES SECURITIES LAWS.

Additional features:

Document: http://n.eqs.com/c/fncls.ssp?u=BQIAVMQLGD [3] Document title: 20170308_LifeWatch_Whistle Blower_EN End of ad hoc announcement Language: English Company: LifeWatch AG Baarerstrasse 139 6300 Zug Switzerland Phone: +41 41 728 67 78 Internet: www.lifewatch.com ISIN: CH0012815459 Valor: 811189 Listed: Regulated Unofficial Market in Berlin, Stuttgart; Open Market in Frankfurt; SIX Swiss Exchange

End of Announcement EQS Group News Service

551437 08-March-2017 CET/CEST

1: http://public-cockpit.eqs.com/cgi-bin/fncls.ssp?fn=redirect&url=793a282d78899898820d3c7e4bf3c48d&application_id=551437&site_id=vwd&application_name=news 2: http://public-cockpit.eqs.com/cgi-bin/fncls.ssp?fn=redirect&url=873f59773724d1b6cd7507597e48246a&application_id=551437&site_id=vwd&application_name=news 3: http://public-cockpit.eqs.com/cgi-bin/fncls.ssp?fn=redirect&url=8b2145a5a765737e0bac4a61ed7d630a&application_id=551437&site_id=vwd&application_name=news (END) Dow Jones Newswires

   March 08, 2017 00:56 ET (05:56 GMT)- - 12 56 AM EST 03-08-17